TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 68 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $7,000 | – | 15,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 300,000 | $1,209,000 | 0.23% |
| Rock Springs Capital Management LP | 698,000 | $2,813,000 | 0.19% |
| Eventide Asset Management | 600,000 | $2,418,000 | 0.16% |
| Teza Capital Management LLC | 14,369 | $58,000 | 0.08% |
| Candriam S.C.A. | 374,000 | $1,507,000 | 0.04% |
| R&F Capital Advisors LP | 23,778 | $96,000 | 0.03% |
| Tekla Capital Management LLC | 192,322 | $775,000 | 0.03% |
| Sunbelt Securities, Inc. | 6,000 | $24,180,000 | 0.03% |
| DOW CHEMICAL CO /DE/ | 65,000 | $249,000 | 0.03% |
| CANADA PENSION PLAN INVESTMENT BOARD | 1,654,100 | $6,666,000 | 0.02% |